Email this article Dufaston (degidrosteron) in treatment of dysfunctional womb bleeding associated with ferrum hyperplasia of endometrium
- Authors: Ulrikh Е.A.1,2, Kutusheva G.F.1,2, Urmancheeva А.F.1,2
-
Affiliations:
- Saint Petersburg Pediatric Medical Academy
- Saint Petersburg State Medical Academy of Postgraduate Education
- Issue: Vol 52, No 3 (2003)
- Pages: 60-63
- Section: Original Research
- URL: https://journals.rcsi.science/jowd/article/view/88982
- DOI: https://doi.org/10.17816/JOWD88982
- ID: 88982
Cite item
Full Text
Abstract
Endometrial hyperplasia, being a fairly common gynecological pathology among women of different age groups, requires timely diagnosis and adequate treatment. Duphaston at a dosage of 10-20 mg from 5 to 25 or from 16 to 25 days of the menstrual cycle showed itself as an effective drug (in 83.3%), with sufficient progestogenic antiproliferative activity, with minimal side effects and a neutral effect on the metabolism of lipids and carbohydrates , which made it possible to use it among patients with various somatic pathologies.
Full Text
##article.viewOnOriginalSite##About the authors
Е. A. Ulrikh
Saint Petersburg Pediatric Medical Academy; Saint Petersburg State Medical Academy of Postgraduate Education
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Saint Petersburg; Saint Petersburg
G. F. Kutusheva
Saint Petersburg Pediatric Medical Academy; Saint Petersburg State Medical Academy of Postgraduate Education
Email: info@eco-vector.com
Russian Federation, Saint Petersburg; Saint Petersburg
А. F. Urmancheeva
Saint Petersburg Pediatric Medical Academy; Saint Petersburg State Medical Academy of Postgraduate Education
Email: info@eco-vector.com
Russian Federation, Saint Petersburg; Saint Petersburg
References
Supplementary files
